TELA Bio (TELA) Non Operating Interest Expenses (2018 - 2026)

TELA Bio has reported Non Operating Interest Expenses for 9 years, with the latest figure at $2.1 million in Q2 2026.

• On a quarterly basis, Non Operating Interest Expenses rose 74.75% year-over-year to $2.1 million in Q2 2026; TTM through Jun 2026 was $7.0 million, a 38.4% increase from a year earlier, with the FY2025 full-year figure at $5.2 million, down 0.85% from the prior year.
• Non Operating Interest Expenses was $2.1 million for Q2 2026 at TELA Bio, up from $2.1 million in the prior quarter.
• The five-year high for Non Operating Interest Expenses was $2.1 million in Q2 2026, with the low at $911000.0 in Q1 2022.
• Average Non Operating Interest Expenses over 5 years is $1.3 million, with a median of $1.3 million recorded in 2023.
• The sharpest annual moves came in 2025 and 2026: Non Operating Interest Expenses decreased 10.74% in 2025, then soared 74.75% in 2026.
• Over 5 years, Non Operating Interest Expenses stood at $1.2 million in 2022, then gained by 14.57% to $1.3 million in 2023, then dropped by 4.61% to $1.3 million in 2024, then grew by 27.59% to $1.6 million in 2025, then increased by 26.82% to $2.1 million in 2026.
• The last three Non Operating Interest Expenses figures came in at $2.1 million (Q2 2026), $2.1 million (Q1 2026), and $1.6 million (Q4 2025), per Business Quant data.